Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL.
Desai AS, et al. Among authors: robbie gj.
N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391.
N Engl J Med. 2023.
PMID: 37467498
Clinical Trial.